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Abstract
Background. Hypernatraemia is common in critically ill
patients and has been shown to be an independent predictor
of mortality. Osmotic urea diuresis can cause hypernatrae-
mia due to significant water losses but is often not diag-
nosed. Free water clearance (FWC) and electrolyte free
water clearance (EFWC) were proposed to quantify renal
water handling. We aimed to (i) identify patients with hy-
pernatraemia due to osmotic urea diuresis and (ii) investi-
gate whether FWC and EFWC are helpful in identifying
renal loss of free water.
Methods. In this retrospective study, we screened a registry
for patients, who experienced intensive care unit (ICU)-
acquired hypernatraemia. Among them, patients with hy-
pernatraemia due to osmotic urea diuresis were detected by
a case-by-case review. Total fluid and electrolyte balances
together with FWC and EFWC were calculated for days of
rising serum sodium and stable serum sodium.
Results. We identified seven patients (10% of patients with
ICU-acquired hypernatraemia) with osmotic diuresis due to
urea. All patients were intubated during development of
hypernatraemia and received enteral nutrition. The median
highest serum sodium level of 153 mmol (Q1: 151–Q3:
155 mmol/L) was reached after a 5-day period of rise in
serum sodium. During this period, FWC was 904 mL/day
(Q1: 1574–Q3: 572), indicating renal water retention,
while EFWC was 1419 mL/day (Q1: 1052–Q3: 1923),
showing renal water loss. While FWC did not differ be-
tween time of stable serum sodium and development of
hypernatraemia, EFWC was significantly higher during rise
in serum sodium.
Conclusion. Osmotic urea diuresis is a common cause of
hypernatraemia in the ICU. EFWC was useful in the differ-
ential diagnosis of polyuria during rising serum sodium
levels, while FWC was misleading.
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Introduction
Intensive care unit (ICU)-acquired hypernatraemia is a
common problem in ICUs with incidence rates of ~10%
and was described to be independently associated with
mortality [1]. Causes of hypernatraemia in critically ill pa-
tients are various but in general, its development is either a
result of a gain of sodium or a loss of free water [2]. Since
critically ill patients are often intubated and/or sedated or
have other reasons for a lack of free access to water, fluid
and electrolyte balance is mainly managed by the physician
[3]. Thus, the development of hypernatraemia in a critically
ill patient indicating that too little water has been provided
was proposed as an indicator of poor quality of care [4].
Given the multitude of adverse effects of hypernatraemia/
hyperosmolality ranging from neurologic dysfunction to de-
creased left ventricular contractility [2, 5–7], an early identi-
fication of the causes of a rising serum sodium in critically ill
patients is crucial for causal treatment and the avoidance of
aggravating or relapsing hypernatraemia.
Osmotic diuresis can lead to significant losses of free
water and can cause or at least contribute to the develop-
ment of hypernatraemia. Osmotic diuresis caused by urea is
often not identified under circumstances of rising serum
sodium levels since the high urine osmolality in compar-
ison to the serum osmolality can be mistaken for renal
retention of free water. Free water clearance (FWC) is often
calculated in order to quantify renal water handling [8].
However, the calculation of FWC is based on osmolality
(which is influenced by the concentration of urea) and
therefore might be prone to failure in patients with urea
diuresis. In contrast, electrolyte free water clearance
(EFWC) is based on the relation of sodium and potassium
in urine to serum sodium concentration and therefore is not
prone to failure under circumstances of osmotic diuresis.
In this study, we wanted to (i) identify and characterize
patients with ICU-acquired hypernatraemia due to osmotic
urea diuresis and (ii) evaluate the benefit of using FWC and
EFWC in the differential diagnosis of polyuria and
hypernatraemia.
Materials and methods
We screened a database of patients who were admitted to a medical ICU of a
tertiary university hospital between June 1 2001 and April 30 2004. Only
patients with hypernatraemia were included. Hypernatraemia was defined as
a serum sodium exceeding 149 mmol/L [1, 9]. Of these patients,
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demographic data, admission diagnosis, severity of disease as measured by
the simplified acute physiology score (SAPS II), daily measurements of
electrolytes, urinalysis, serum and urine osmolality, detailed information
on administered infusion and nutrition solutions were obtained. In order
to identify patients with hypernatraemic episodes due to osmotic urea diu-
resis, we performed a case-by-case review of the days in the ICU during
which serum sodium was rising prior to hypernatraemia. In a first step,
screening for patients with polyuria (urine output >2.000 mL/day at least
once during rise of serum sodium) was performed. In a second step, water
diuresis (urine osmolality < 150 mmol/L) was excluded [10]. Patients were
considered to have solute diuresis when urine osmolality was >300 mmol/L
at time of polyuria [10, 11]. Additionally, a total daily osmole excretion of
>1000 mmol as calculated by the following equation: daily osmole excre-
tion ¼ osmolalityurine 3 volumeurine (in liters), was necessary for the pres-
ence of solute diuresis at least once during rise in serum sodium.
To differentiate the cause for the solute diuresis, the following steps
were performed to rule out osmotic diuresis due to glucose; only patients
with negative tests for glucose in urine during the time of rising serum
sodium levels were included. Cases were reviewed for the administration
of mannitol in order to rule out solute diuresis due to mannitol. In order to
differentiate between an electrolyte diuresis from a urea diuresis, concen-
trations for both were calculated from urinalysis. Osmotic diuresis due to
urea was considered present in a patient if urea concentration in urine was
exceeding 250 mmol/L [10, 12]. Additionally, the fraction of the osmo-
lality in the urine caused by urea had to be outweighing the fraction caused
by sodium and potassium. For all identified patients, in order to discrim-
inate whether urea stems from protein out of the administered enteral
nutrition or from catabolism, we calculated protein balances as follows.
In a first step, protein equivalent was calculated from daily urea output.
In order to convert urea in urine (in mmol) to blood urea nitrogen (BUN, in
mg/dL), we calculated:
BUN ¼ Ureaurine 3 2:8 3 0:467:
The product was multiplied with the urine volume, which gave us daily
nitrogen output which finally was multiplied by 6.25 to receive the protein
equivalent.
Finally, protein intake as calculated from enteral nutrition and protein
equivalent allowed calculation for protein balances.
Moreover, we calculated FWC and EFWC as modified by Kurtz for the
days during which serum sodium rose [8, 13]:
FWC ¼ Volurine3
h
1 

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
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In order to make our findings more illustrative, we also characterized 10
patients with ICU-acquired hypernatraemia due to sodium gain.
Correlations and paired t-tests were computed using Statistica Version
9.1, Statsoft Inc. Tulsa, Oklahoma. Results are presented as counts and
percentages and as median, first and third quartile. A P-value <0.05 was
considered significant.
Results
Of a total of 981 patients admitted to the ICU during the
study period, 69 (7% of all patients) were identified with
ICU-acquired hypernatraemia. Of these, seven patients
(10% of the hypernatraemic patients) were determined to
have hypernatraemia due to osmotic urea diuresis. Patient
characteristics are given in Table 1. All patients received
enteral nutrition during time of rise in serum sodium and
were intubated and sedated. All patients were normonatrae-
mic on admission except for one patient who was hypona-
traemic. During ICU stay, serum sodium began to rise to
finally reach hypernatraemia. Median duration of rise of
serum sodium was 5 days (4–6), mean rise in serum sodium
was 12 mmol/L (11–16) and maximum sodium level was
153 mmol/L (151–155). During rise of serum sodium, none
of the patients received either furosemide or mannitol. Five
patients received hydrocortisone treatment during the rise
in serum sodium and six patients received catecholamines.
Figure 1 shows the course of serum sodium starting with
the day of rise until the maximum sodium concentration.
During rise of serum sodium, total infused volume was
3948 mL (2753–4918) per day, while total volume output
was 2595 mL (1890–3000) per day. Mean central venous
pressure was 16 mmH2O (14–18), not corrected for positive
end expiratory pressure. Serum osmolality was 320 mmol/L
(317–336) and urine osmolality was 494 mmol/L (454–569).
Serum creatinine during rise in serum sodium was 112 lmol/
L (93–124) and blood urea nitrogen was 22 mmol/L (16–30).
Five patients experienced acute kidney injury during their
ICU stay according to the RIFLE criteria (two patients with
a rise in serum creatinine31.5 and three patients with a rise
3 2) [14]. Urea in urine was 369 mmol/L (295–415) and
accounted for 71% (60–77) of total osmoles in urine as cal-
culated by the following formula:
ðUrea in urine ðmmol=LÞ=urine osmolality ðmmol=LÞÞ3100:
Total daily osmole excretion was 1051 mmol (822–
1313).
Protein intake during the rise in serum sodium via enteral
nutrition was 56 g/day (66–80) and median calculated pro-
tein equivalent output was 60 g/day (47–73), resulting in a
median protein balance of 10 g/day (37 to 6). The frac-
tional excretion of sodium was 0.19% (0.12–0.31) and the
fractional excretion of urea was 36% (26–47).
During the rise in serum sodium, FWC was negative for
all patients and all patient days with a median of 904 mL/
day (1574 to 572), indicating renal water retention. In
contrast, EFWC was positive for all patients and all patient
days with a mean value of 1419 mL/day (1052–1923),
indicating renal water loss. Box plots of FWC versus
EFWC during the rise in serum sodium are given in Figure
2. Both, FWC (R ¼ 0.4 and R ¼ 0.4, P < 0.05) as well
as EFWC (R ¼ 0.5 and R ¼ 0.8, P < 0.05) correlated
positively with total volume loss and urine output in
patients. EFWC, but not FWC, significantly correlated with
the fraction of urea on total urine osmolality (R ¼ 0.5,
P < 0.05; R ¼ 0.2, respectively). Total fluid balances
[1415 (107–2427) versus 1091 (300 to 2096) mL; P ¼
0.6] as well as total urine output [2075 (1653–2763) versus
2475 (1420–3088) mL; P ¼ 0.2] did not differ during de-
velopment of hypernatraemia and times of stable serum
Table 1. Characteristics of patients with ICU-acquired hypernatraemia
due to osmotic urea diuresis
N
Sex (male/female) 4 (57%)/3 (43%)
Age (years) 61 (SD 12)
SAPSII score on admission 50 (SD 18)
Plasma creatinine on ICU admission (mg/dL) 1.42 (SD 0.6)
ICU length of stay (days) 19 (SD 9)
ICU mortality 29%
Main cause of ICU admission
Respiratory 3 (43%)
Circulatory 3 (43%)
Gastroenterologic/hepatologic 1 (14%)
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sodium. EFWC during rise in serum sodium was signifi-
cantly higher than during time of stable serum sodium
[1419 [1052–1923) versus 805 (527–1200) mL; P <
0.01]. FWC during development of hypernatraemia did
not differ from FWC during time of stable serum sodium
[904 (1574 to 572) versus 987 (1466 to 525]
mL; P ¼ 0.98]. Table 2 gives an overview of fluid and
electrolyte balances of days of rising serum sodium com-
pared to days with stable serum sodium.
In order to illustrate the pathophysiologic mechanisms
leading to hypernatraemia due to osmotic diuresis, we also
describe 10 patients with episodes of ICU-acquired hyper-
natraemia due to sodium gain. Patients with ICU-acquired
hypernatraemia mainly due to sodium gain had a similar
volume output [1965 mL (1430–2880), P ¼ 0.44]
compared to patients with osmotic urea diuresis. EFWC
was lower with 517 mL (137–778), P < 0.01, less urea
in urine with 154 mmol/L (108–227), P < 0.01, and urea
Fig. 1. Rise of serum sodium in seven patients with osmotic urea diuresis.
Fig. 2. Box plots of the median FWC versus EFWC calculated while serum sodium was rising to overt hypernataremia.
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accounted for 37% (28–45) of osmoles in urine, while so-
dium and potassium was higher with 204 mmol/L (168–
227), P < 0.01, and sodium and potassium accounted for
57% (39–61) of osmoles in urine.
Discussion
In this study, we characterized a series of patients with
ICU-acquired hypernatraemia caused by osmotic urea diu-
resis. We showed that calculation of FWC as a measure of
renal water handling, as often postulated in textbooks and
publications [15–17], is misleading in the setting of os-
motic urea diuresis. On the contrary, calculation of EFWC
explicitly indicated renal loss of free water as the cause of
rising serum sodium levels.
The association of tube feeding with hypernatraemia and
azotaemia was made early in the literature [18, 19]. How-
ever, current studies focusing on the etiology of hyperna-
traemia in critically ill patients often do not take this
important constellation into account [4]. Previous studies
could show the association between the occurrence of hy-
pernatraemia in the ICU and an increase in mortality [1,
20–24]. This together with known effects of hypernatrae-
mia on metabolism and cardiac as well as neurologic func-
tion should create awareness for rising serum sodium levels
[2, 7, 25–27]. When serum sodium begins to rise, a thor-
ough analysis of fluid and electrolyte balance on basis of
total infused fluids and nutrition solutions as well as fluid
and electrolyte output as measured by urinalysis is
indicated.
Urea, given in order to provoke osmotic diuresis, is used
as a treatment for hyponatraemia in the syndrome of inap-
propriate secretion of antidiuretic hormone and was re-
cently described to be complicated by the occurrence of
hypernatraemia in some critically ill patients [28–30].
Despite this, osmotic urea diuresis certainly is not the first
differential diagnosis in most physicians’ minds when
confronted with rising serum sodium values. Thus, formu-
las to assist the physician in making a differential diagnosis
of polyuria and rising serum sodium levels are available.
FWC has been mentioned in the medical literature for many
years as a tool to mark renal water handling [15–17].
However, it is based on the relation of urine osmolality
to plasma osmolality and is therefore prone to failure in
the setting of osmotic diuresis. In this study, we showed
that the calculation of FWC can be misleading in the differ-
ential diagnosis of polyuria with rising serum sodium. The
Edelman equation [31]
Serum ½Naþserum ¼ ðNaþ þ KþÞexchangeable
.
TBW
shows that the serum sodium concentration ([Na1]serum is
determined by the relation of total exchangeable sodium
and potassium in the body [(Na1 1 K1)exchangeable]) and
the total body water (TBW). Thus, it seems logical that the
osmolality-based FWC has no role in the differential diag-
nosis of sodium disorders.
On the contrary, EFWC, based on the relation of urinary
sodium and potassium to serum sodium clearly showed
ongoing renal loss of free water in our patients, making it
a valuable tool in the differential diagnosis of polyuria and
consequently hypernatraemia. Especially in the intensive
care setting, where urinalysis and 24 h urine measurement
are often performed routinely, the calculation of EFWC
under circumstances of rising serum sodium values can
be of help in the differential diagnosis of polyuria and
hypernatraemia. Additionally, EFWC might help guiding
therapy for the correction of hypernatramia. It allows an
estimation of how much free water is lost at the moment,
which is equal to the minimum amount of free water that
has to be given to the patient in order to at least keep the
momentary serum sodium. The increasing use of tablet
PC’s and smartphones allows for rapid bedside calcula-
tion of EFWC.
It should also be mentioned that in the ICU losses of
electrolyte free water/hypotonic fluids are often substituted
by use of isotonic infusions creating a positive sodium
balance that ultimately results in a rise of serum sodium.
In our patients, the positive fluid balance during rise in
Table 2. Fluid and electrolyte balances of patients during development of hypernatraemia and during time of stable serum sodiuma
Rise of sodium (Q1–Q3) Stable sodium (Q1–Q3) P-value
Volume input (mL) 3948 (2753–4918) 3342 (2597–5128) 0.9
Volume output (mL) 2595 (1890–3000) 2480 (1510–3510) 0.4
Urine in 24 h (mL) 2075 (1653–2763) 2475 (1420–3088) 0.2
Volume balance (mL) 1415 (107–2427) 1091 (300 to 2096) 0.06
Na 1 K input (mmol) 220 (97–469) 197 (109–339) 0.8
Na 1 K output (mmol) 146 (89–180) 236 (133–424) <0.01
Na 1 K balance (mmol) 50 (55 to 363) 65 (204 to 134) 0.02
FWC (mL) 904 (1574 to 572) 987 (1466 to 522) 0.9
EFWC (mL) 1419 (1052–1923) 805 (527–1200) <0.01
Urea in urine (mmol) 369 (295–415) 241 (152–331) <0.01
Na 1 K in urine (mmol) 97 (68–156) 188 (130–258) <0.01
%Urea of osmolality (%) 71 (60–77) 53 (39–66) <0.01
%Na 1 K of osmolality (%) 19 (14–27) 43 (25–57) <0.01
aWhile Na1K stands for sodium and potassium, %urea of osmolality for the fraction of urea on total urine osmolality and %Na1K of osmolality for the
fraction of sodium and potassium on total urine osmolality. Values are presented as median and first and third quartiles.
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serum sodium is notable since it indicates that a sodium
gain contributed to the development of hypernatraemia:
Patients lost hypotonic fluid with urine due to the osmotic
urea diuresis. At the same time, these losses were replaced
by isotonic fluids which in fact were hypertonic compared
to the urine thus resulting in a gain of sodium. It might be
due to a common fear to create hyponatraemia that hypo-
tonic solutions are only seldom administered in the ICU.
However, calculation of EFWC as shown above serves as a
guide to find the amount of free water needed to keep the
actual serum sodium value at its level. Under normal con-
ditions, the conventional calculation of EFWC as proposed
by Rose should be sufficient and is easier to use than the
modified formula by Kurtz used in this study [8]:
EFWC ¼ Volurine3

1  Naþ þ Kþurine

osmoplasma

:
In daily clinical practice, when serum sodium starts to
rise in a patient who is receiving enteral nutrition (or is in
a catabolic state), polyuria combined with a high urea in
urine which is exceeding the amount of sodium and po-
tassium in urine should be considered a hint for the pres-
ence of osmotic urea diuresis without use of formulas.
Under these circumstances, steps should be undertaken
to reduce the urea load for the patient or if this is not
possible to provide enough free water (e.g. via enteral
tube) to avoid a further rise in serum sodium. Neverthe-
less, calculation of EFWC will rapidly answer the ques-
tion of whether renal loss of free water is present or not. In
any case of rising serum sodium, urine chemistry is nec-
essary to determine the cause.
In our patients, we tried to differentiate whether urea
stemmed from enteral nutrition or catabolism, which was
difficult since five of the patients experienced acute kidney
injury during their ICU stay, making the comparison of
actual protein intake by enteral nutrition and the calculated
protein equivalent output difficult. Moreover, administra-
tion of steroids as often performed in critically ill patients
led to an increase in protein catabolism. It should be
mentioned that five of the patients fulfilled RIFLE
criteria for acute kidney injury. However, the absolute rise
in creatinine in these patients makes a significant concen-
tration defect unlikely so this should not be influencing our
results.
Our study is limited by its retrospective design and the
small patient number. The potentially helpful role of calcu-
lation of EFWC in the differential diagnosis of hypernatrae-
mia in critically ill patients should be examined in a
prospective study. Fractional excretion of sodium was
quite low in our patients potentially indicating volume con-
traction. On the other hand, central venous pressure was 16
mmH2O, which at least should rule out more severe
hypovolaemia.
In conclusion, we present a series of seven critically ill
patients with ICU-acquired hypernatraemia with the often
neglected diagnosis of osmotic urea diuresis. We could
show that calculation of EFWC identifies ongoing renal
loss of free water, while the classic FWC indicates water
retention by the kidney. Physicians should be aware of
osmotic diuresis due to urea as the cause of polyuria and
rising serum sodium values.
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